Bengaluru to host 6th World Oral Cancer Congress in May

The city will host 6th World Oral Cancel Congress from May 17 to 20. This was announced by Dr. Moni Abraham Kuriakose, President of Indian Head & Neck Cancer Society, during the inauguration of the India chapter of International Academy of Oral Oncology (IAOO), a multi-disciplinary international organisation with its head office in New York, in Bengaluru.

This academic forum brings together clinicians and scientists, working on issues related to the cause, epidemiology, prevention, biology and management of oral cancer.

Dr. Sanjeev Nair, president of the IAOO India chapter, said, “Formation of this multi-disciplinary forum that not only includes the professionals but also the patient advocacy group and NGOs is anticipated to sustain the various anti-oral cancer efforts that will be discussed at the congress”. 

A series of twelve IAOO regional meeting were carried out around the country during the past year to improve awareness of oral cancer both among the public and the professionals.

Dr. Moni Abraham Kuriakose gave an overview of the International Academy of Oral Oncology and announced that India, where oral cancer is the leading cause of cancer related morbidity and mortality, will be hosting the World Oral Cancer Congress in Bengaluru from 17th to 20th May, 2017.  

“For India, the world oral cancer congress is conceived not just as an event, but a mission to eradicate oral cancer”, said Dr. Moni Abraham Kuriakose, Chairman of the IAOO world congress. This is the first time that India will be hosting the International conference on oral oncology. 

“I congratulate the International Academy of Oral Oncology on the launch of their India Chapter and welcome the fact that the 6th World Oral Cancer Congress is being held here with the mission of eradicating oral cancer in India. We, at Biocon, have been running a crusade against oral cancer through patient outreach programs of our Oncology division as well as early detection and screening initiatives of our CSR arm, Biocon Foundation. The comprehensive campaign against one of the most common forms of cancer in the country is facilitating regular screening of vulnerable populations to detect the disease on time and ensuring better treatment outcomes and longer survival”, said Kiran Mazumdar Shaw, CMD, Biocon.

The conference in Bengaluru will see participants from around 33 countries and more than a 1000 delegates from across the globe.



Popular posts from this blog

EMA Recommends Extension of Indications for Ramucirumab

Dr. Hootie Warren takes helm of Fred Hutch Global Oncology

Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration to Evaluate Combination of Opdivo (Nivolumab) and Rubraca® (Rucaparib) in Phase 2 and Pivotal Phase 3 Clinical Trials in Multiple Tumor Types